Centessa Pharmaceuticals plc

NASDAQ:CNTA

17.16 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -151.085-216.207-381.854-10.663-5.061
Depreciation & Amortization 0.810.1310.03400.006
Deferred Income Tax -26.529-2.857-6.80400.001
Stock Based Compensation 29.39224.96514.8520.3360.236
Change In Working Capital -18.858-2.831-5.378-0.489-1.006
Accounts Receivables 0-11.704-6.72100
Inventory 011.704-4.15700
Accounts Payables -2.7336.3514.157-0.0490.855
Other Working Capital -16.125-9.1821.343-0.44-1.861
Other Non Cash Items 5.928-3.747257.8460.186-0.001
Operating Cash Flow -160.342-200.546-136.142-10.63-5.825
Investing Activities:
Investments In Property Plant And Equipment -0.169-1.137-0.18600
Acquisitions Net 0063.43400
Purchases Of Investments -126.8350000
Sales Maturities Of Investments 00000
Other Investing Activites 00.206-000
Investing Cash Flow -127.004-0.93163.24800
Financing Activities:
Debt Repayment 0073.931.3613.831
Common Stock Issued 20.8070.718586.4420.010
Common Stock Repurchased 00-0.01200
Dividends Paid 00000
Other Financing Activities 0.310.457586.1380.0015.174
Financing Cash Flow 21.1170.457660.0681.3629.005
Other Information:
Effect Of Forex Changes On Cash 0.615-0.4181.902-0.0750.52
Net Change In Cash -265.614-201.438590.079-9.3433.7
Cash At End Of Period 128.03393.644595.0827.22716.57